Key takeawaysTwo years after receiving an investigational gene therapy as part of a clinical trial co-led by UCLA's Dr.

InVitria, a leading developer of recombinant, chemically defined components for biomanufacturing, has announced the launch of Optibumin® 25, the first and only recombinant human serum albumin (rHSA) ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

As Lagos State marked the 2025 World Malaria Day, the government has announced that its malaria prevalence rate has dropped to 1.3 percent, marking a significant step towards pre-elimination as ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

A team of Canadian researchers has developed a curriculum framework to help train future family physicians in the use of ...

For many businesses, there's no question that agentic AI will be a game changer, unlocking the value of data that's been ...

With a workforce shortage and increasing patient demands, it is important for clinical practice leaders in primary care to ...

Panaji: With unseasonal rain hitting the state, the health department is gearing up to ensure dengue doesn’t raise its head ...

The future of medicine will belong to the physicians who are empowered, not sidelined, by technology. And to the patients who ...

Canada's three major political parties finished Election Day with class, as they welcomed a united future for Canadians ...

They’re coming from Big Law, the Ivy League, arts institutes and beyond, brimming with smarts and energy and united by a ...